Company profile
Veradermics, Inc
NYSE:MANEBiotechnology: Pharmaceutical Preparations
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06724614 | phase2_3 | active_not_recruiting | 2024-11-06 | 2026-02-01 | Veradermics, Inc. | Efficacy and Safety of VDPHL01 in Males With AGA |
| NCT05799157 | phase2 | completed | 2023-02-28 | 2025-02-25 | Veradermics, Inc. | Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts |
| NCT07146022 | phase3 | active_not_recruiting | 2025-07-25 | 2027-06-01 | Veradermics, Inc. | Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA) |
| NCT06972264 | phase3 | active_not_recruiting | 2025-03-11 | 2026-12-01 | Veradermics, Inc. | Safety and Efficacy of VDPHL01 in Males With AGA |
| NCT06527365 | phase2 | active_not_recruiting | 2024-07-08 | 2026-08-01 | Veradermics, Inc. | Safety and Efficacy of VDPHL01 in Males and Females With AGA |
FDA applications (0)
No records yet.